Download (534Kb) - Repozitorij Medicinskog fakulteta Sveučilišta u ...

122. Fabiani B, Delmer A, Lepage E, et al. CD10 expression in diffuse large B-cell lymphomas does notinfluence survival. Virchow Arch 2004;445:545-51.123. Zhang X, Karnan S, Tagawa H, et al. Comparison of genetic aberrations in CD10+ diffused large B-cell lymphoma and follicular lamphoma by comparative genomic hybridization and tissue-fluorescencein situ hybrdization. Cancer Sci 2004,95:809-14.124. Nguyen H, Hiscott J, Pitha PM. The growing family of interferon regulatory factors. Cytokine GrowthFactor Rev 1997;8:293-312.125. Tsuboi K, Iida S, Inagaki H, et al. MUM1/IRF4 expression as a frequent event in mature lymphoidmalignancies. Leukemia 2000;14:449-56.126. Iida S, Rao PH, Butler M, et al. Deregulation of MUM1/IRF4 by chromosomal translocation inmultiple myeloma. Nat Genet 1997;17:226-30.127. Carbone A, Gloghini A, Larocca LM, et al. Expression profile of MUM1/IRF4, BCL-6, andCD138/syndecan-1 defines novel histogenetic subset of human immunodeficiency virus-relatedlymphomas. Blood 2001;97:744-51.128. Falini B, Fizzotti M, Pucciarini A, et al. A monoclonal antibody (MUM1p) detects expression of theMUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood2000;95:2084-92.129. Sanderson RD, Lalor P, Bernfield M. B lymphocytes express and lose syndecan at specific stages ofdifferentiation. Cell Regul 1989;1:27-35.130. Yang Y, Yaccoby S, Liu W, et al. Soluble syndecan-1 promotes growth of myeloma tumors in vivo.Blood 2002;100:610-7.131. Sanderson RD, Borset M. Syndecan-1 in B lymphoid malignancies. Ann Hematol 2002;81:125-35.132. Linderoth J, Jerkeman M, Cavallin-Stahl E, Kvaloy S, Torlakovic E. Immunohistochemical expressionof CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma:a Nordic Lymphoma Group Study. Clin Cancer Resch 2003;9:722-8.